Addus HomeCare Corporation $ADUS Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC lowered its position in Addus HomeCare Corporation (NASDAQ:ADUS) by 43.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,243 shares of the company’s stock after selling 5,525 shares during the quarter. Intech Investment Management LLC’s holdings in Addus HomeCare were worth $778,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Royal Bank of Canada increased its stake in shares of Addus HomeCare by 24.3% during the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after acquiring an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after acquiring an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC increased its stake in shares of Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after acquiring an additional 8,780 shares during the period. Finally, Cetera Investment Advisers increased its stake in shares of Addus HomeCare by 28.8% during the second quarter. Cetera Investment Advisers now owns 4,796 shares of the company’s stock valued at $552,000 after acquiring an additional 1,073 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Trading Down 1.5%

Shares of NASDAQ:ADUS opened at $90.71 on Tuesday. The stock has a market capitalization of $1.69 billion, a price-to-earnings ratio of 16.77, a PEG ratio of 1.26 and a beta of 0.89. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The company has a 50 day moving average price of $93.83 and a 200 day moving average price of $103.76.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. During the same quarter last year, the business posted $1.42 EPS. The company’s revenue was up 7.7% on a year-over-year basis. On average, research analysts anticipate that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ADUS shares. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Wednesday, February 25th. Weiss Ratings lowered shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Barclays reduced their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Finally, Stephens reduced their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.